Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations Meeting Abstract

  

Authors:	Sandhu, S.; Attard, G.; Olmos, D.; Efstathiou, E.; Castro, E.; Rathkopf, D. E.; Smith, M. R.; Roubaud, G.; Small, E. J.; Gomes, A. J.; Saad, M.; Tural, D.; Thomas, S.; Urtishak, K.; Gormley, M.; Mason, G.; Diorio, B.; Wang, G. C.; Lopez-Gitlitz, A.; Chi, K. N.
Abstract Title:	Gene-by-gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680301437
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.5020
Notes:	Meeting Abstract: 5020 -- Meeting also held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201549